HLA-DR in cytotoxic T lymphocytes predicts breast cancer patients' response to neoadjuvant chemotherapy

This work was supported by iNOVA4Health - UID/Multi/04462/2013 - LISBOA-01-0145-FEDER-007344, Fundacao para a Ciencia e Tecnologia - PD/BD/114023/2015 and PTDC/BBB-BMD/4497/2014. Liga Portuguesa Contra o Cancro.

Bibliographic Details
Main Author: Saraiva, Diana P. (author)
Other Authors: Jacinto, António (author), Borralho, Paula (author), Braga, Sofia (author), Cabral, M. Guadalupe (author)
Format: article
Language:eng
Published: 2018
Subjects:
Breast cancer
Cytotoxic T lymphocytes
HLA-DR
Neoadjuvant chemotherapy
Prediction
Immunology and Allergy
Immunology
SDG 3 - Good Health and Well-being
Online Access:https://doi.org/10.3389/fimmu.2018.02605
Country:Portugal
Oai:oai:run.unl.pt:10362/54695

Internet

https://doi.org/10.3389/fimmu.2018.02605

Similar Items